Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac (CVAC) Gross Profit (2019 - 2025)

Historic Gross Profit for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $62.8 million.

  • CureVac's Gross Profit fell 8787.5% to $62.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.7 million, marking a year-over-year decrease of 8218.56%. This contributed to the annual value of $458.8 million for FY2024, which is 70392.61% up from last year.
  • According to the latest figures from Q3 2025, CureVac's Gross Profit is $62.8 million, which was down 8787.5% from -$1.1 million recorded in Q2 2025.
  • CureVac's Gross Profit's 5-year high stood at $518.3 million during Q3 2024, with a 5-year trough of -$101.1 million in Q3 2021.
  • Moreover, its 5-year median value for Gross Profit was -$14.5 million (2023), whereas its average is $9.3 million.
  • As far as peak fluctuations go, CureVac's Gross Profit tumbled by 235997.53% in 2021, and later skyrocketed by 620599.93% in 2024.
  • Quarter analysis of 5 years shows CureVac's Gross Profit stood at -$33.0 million in 2021, then crashed by 111.38% to -$69.7 million in 2022, then skyrocketed by 52.14% to -$33.3 million in 2023, then surged by 141.7% to $13.9 million in 2024, then surged by 351.89% to $62.8 million in 2025.
  • Its Gross Profit was $62.8 million in Q3 2025, compared to -$1.1 million in Q2 2025 and $18933.9 in Q1 2025.